Quince Therapeutics (QNCX)
NASDAQ:QNCX
Quince Therapeutics (QNCX) Ownership Overview
14.86% Insiders
4.02% Mutual Funds
19.40% Other Institutional Investors
3.73% ETFs
57.99% Public Companies and
Individual Investors
The ownership structure of Quince Therapeutics (QNCX) stock is a mix of institutional, retail, and individual investors. Approximately 27.15% of the company’s stock is owned by Institutional Investors, 14.86% is owned by Insiders, and 57.99% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 29, 2025 | xxxxxxxxxxxxx | $173500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $6504165 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,686,387 | Insider | 12.01% | 695,384 | |
| 1,949,061 | Institution | 3.50% | 202,702 | |
| 1,941,542 | Institution | 3.49% | 201,920 | |
| 1,754,361 | Institution | 3.15% | 182,454 | |
| 994,885 | Insider | 1.79% | 103,468 | |
| 368,415 | Institution | 0.66% | 38,315 | |
| 361,827 | Insider | 0.65% | 37,630 | |
| 130,009 | Insider | 0.23% | 13,521 | |
| 125,206 | Institution | 0.22% | 13,021 | |
| 89,179 | Insider | 0.16% | 9,275 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,754,361 | Institution | 3.15% | 182,454 | |
| 368,415 | Institution | 0.66% | 38,315 | |
| 72,922 | Institution | 0.13% | 7,584 | |
| 27,442 | Institution | 0.05% | 2,854 | |
| 12,238 | Institution | 0.02% | 1,273 | |
| 3,075 | Institution | <0.01% | 320 | |
| 1,096 | Institution | <0.01% | 114 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,487,584 | Institution | 2.67% | 252,889 | |
| 461,477 | Institution | 0.83% | 78,451 | |
| 125,206 | Institution | 0.22% | 13,334 |
FAQ
Who Owns Quince Therapeutics (QNCX)?
According to the latest TipRanks data, approximately 19.40% of the company's stock is held by institutional investors, 14.86% is held by insiders, and 57.99% is held by retail investors.
What percentage of Quince Therapeutics (QNCX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.40% of Quince Therapeutics (QNCX) stock is held by institutional investors.
What percentage of Quince Therapeutics (QNCX) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.99% of Quince Therapeutics (QNCX) stock is held by retail investors.
Who owns the most shares of Quince Therapeutics (QNCX)?
David Lamond owns the most shares of Quince Therapeutics (QNCX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.